Ernst emphasized the strategic transformation of Tivic into a diversified therapeutics company, combining biologic and bioelectronic approaches to address immune dysregulation. This includes ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

Amvuttra’s clearance in a rare form of cardiomyopathy could help Alnylam turn a regular profit — if it can wrest control of a ...

The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...

While AI adoption in GMP settings is still evolving, regulatory agencies emphasize explainability and validation of AI models ...

Furthermore, new drug targets identified through these methods still require time-consuming and resource-intensive preclinical and clinical validation. From laboratory research to animal experiments ...

The Ravi Road Police made a significant breakthrough on Thursday by arresting a suspect involved in the manufacturing and distribution of ice, a highly dangerous and illegal drug, in Lahore.

A drug shortage is when a drug manufacturer isn't able to supply enough of a drug to meet all of its Canadian orders on time. The words drug, medication and medicine are often used interchangeably.

They do not apply to natural health products, veterinary drugs or over-the-counter drugs. Since March 2017, manufacturers have been mandated to report actual and anticipated drug shortages and ...

The drug manufacturer sits this part of the process out so that the name remains based purely on the drug’s chemical structure and allows prescribers globally to communicate about a drug without ...